Last reviewed · How we verify

NCT06236711

Transcranial Direct Current Stimulation (tDCS) as an Adjunctive Treatment for Treatment Resistant Depression (TRD)

Active, enrolled NA Last updated 6 November 2025
What this trial tests

NA trial testing tDCS in Treatment Resistant Depression in 10 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
20 March 2025
Primary endpoint
15 October 2025
31 December 2026

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date20 March 2025
Primary completion15 October 2025
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Treatment Resistant Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The researchers are trying to test the feasibility and acceptability of using transcranial Direct Current Stimulation (tDCS) in hospitalized adult patients with Treatment Resistant Depression (TRD), assess for any preliminary effect on depressive and cognitive symptoms, and explore the utility of biomarkers to assess response to tDCS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Transcranial direct current simulation as an adjunctive treatment for treatment-resistant depression in hospitalized patients: A feasibility study protocol.
    Li JW, Ren C, Pazdernik VK, Kung S, et al · · 2025 · PMID 40493630 · DOI 10.1371/journal.pone.0324808

Verify or expand the search:

Other trials of tDCS

Trials testing the same drug.

Other recruiting trials for Treatment Resistant Depression

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06236711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing